Home Top News and Stories Business News Headlines Shilpa Medicare Rating ‘Add’; USFDA warning letter to delay new approvals

Shilpa Medicare Rating ‘Add’; USFDA warning letter to delay new approvals

0
   

Shilpa Medicare Rating ‘Add’; USFDA warning letter to delay new approvals

FY21-23e EPS down 7-10% and TP lowered to Rs 580 from Rs 638; outlook is positive; ‘Add’ maintained